FRNM
Freenome, Inc.Company Information
- Company Name
- Freenome, Inc.
- CIK
- CIK0002017526
- Category
- <br>Emerging growth company
- Ticker: Exchange
- FRNM: Nasdaq, PCSC: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 8071
- SIC Description
- Services-Medical Laboratories
- Ticker
- FRNM
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- —
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 8,623,369
- Shares outstanding
- 8,459,284
- Ownership
- 101.94%
Earnings Market Reaction
- Filing date
- 2026-07-15
- Price on filing date
- —
- 1-month reaction
- -6.07%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | |||||||||||||||
| Cash | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Prepaid Expense Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Assets Held In Trust Noncurrent | 85 | 93 | 92 | 91 | 90 | 89 | 89 | 88 | 86 | ||||||
| Assets | 86 | 93 | 93 | 92 | 91 | 91 | 90 | 89 | 88 | ||||||
Liabilities Current | |||||||||||||||
| Accrued Liabilities Current | 4 | 3 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities Current | 4 | 3 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities | 7 | 6 | 6 | 4 | 4 | 4 | 4 | 4 | 3 | ||||||
| Temporary Equity Carrying Amount Attributable To Parent | 85 | 93 | 92 | 91 | 90 | 89 | 88 | 87 | 86 | ||||||
Stockholders Equity | |||||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Retained Earnings Accumulated Deficit | -6 | -6 | -5 | -3 | -2 | -2 | -2 | -2 | -2 | ||||||
| Stockholders Equity | -6 | -6 | -5 | -3 | -2 | -2 | -2 | -2 | -2 | ||||||
| Liabilities And Stockholders Equity | 86 | 93 | 93 | 92 | 91 | 91 | 90 | 89 | 88 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | - | - | - | - | - | - | - | 0.00 | 0.00 | ||||||
| Common Stock Shares No Longer Subject To Forfeiture | - | - | 0 | - | - | - | - | - | - | ||||||
Select a line item above to chart it.
Recent filings
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialFreenome, Inc. (FRNM) — SEC Financial Statements & Analysis
Freenome, Inc. (FRNM) is a services-medical laboratories company, incorporated in DE. Freenome, Inc. trades on Nasdaq as: FRNM, PCSC. Freenome, Inc. (FRNM)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-07-15. Based on that filing, Freenome, Inc. carries a market cap of $92.04M, a P/E ratio of -120.68x, a P/B ratio of -14.62x, an enterprise value of $91.60M, and an EV/EBITDA multiple of -21.15x. On profitability, it posts a Return on Equity (ROE) of 17.81% and a Return on Assets (ROA) of -0.86%. Per share, it reports EPS of $-0.09, diluted EPS of $-0.09, free cash flow per share of $-0.11, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of -123.42% year-over-year and EPS growth of -123.88% year-over-year. On the balance sheet, it maintains a current ratio of 0.20x, a quick ratio of 0.19x, working capital of $-2.89M, a debt-to-equity ratio of -1.12x, a debt ratio of 0.08, free cash flow of $-907.04K (TTM), and net debt of $-437.37K. Figures sourced from SEC EDGAR.
- Market Cap
- $92.04M
- P/E TTM
- -120.68x
- EPS TTM
- $-0.09
- P/B TTM
- -14.62x
- ROE TTM
- 17.81%
- ROA TTM
- -0.86%
- Debt To Equity
- -1.12x
- Free Cash Flow TTM
- $-907.04K
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Freenome, Inc. in?
Freenome, Inc. (FRNM) operates in the Services-Medical Laboratories industry.
What exchange does FRNM trade on?
Freenome, Inc. (FRNM) trades on the Nasdaq.
Where is Freenome, Inc. incorporated?
Freenome, Inc. is incorporated in DE.
When was Freenome, Inc. (FRNM)'s most recent SEC filing?
Freenome, Inc. (FRNM)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-07-15.
What is FRNM's market cap?
Freenome, Inc. (FRNM) has a market capitalization of $92.04M as of 2026-06-30.
What is FRNM's EPS (earnings per share)?
Freenome, Inc. (FRNM)'s trailing twelve month EPS is $-0.09 as of 2026-06-30.
What is FRNM's ROE (return on equity)?
Freenome, Inc. (FRNM)'s trailing twelve month Return on Equity (ROE) is 17.81% as of 2026-06-30.
What is FRNM's ROA (return on assets)?
Freenome, Inc. (FRNM)'s trailing twelve month Return on Assets (ROA) is -0.86% as of 2026-06-30.
What is FRNM's EV/EBITDA?
Freenome, Inc. (FRNM)'s trailing twelve month EV/EBITDA is -21.15x as of 2026-06-30.